Ruairi J Mackenzie
Technology Networks
RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years, where he also worked on the site’s SEO and editorial AI strategies. He created the site’s podcast, Opinionated Science, in 2020. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.
Got a question for Ruairi J Mackenzie?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 609
Podcast
Opinionated Science Episode 30: Psychedelics: A Trip Through Psilocybin and MDMA Research
On this week’s Opinionated Science, the team takes a look at the growing potential of psychedelic medicine. In this episode, we take a deep dive into four leading psychedelic compounds: psilocybin, MDMA, ketamine and DMT.
News
Intermittent Fasting Less Effective at Burning Body Fat Than Daily Dieting
A new study suggests that the popular dietary technique intermittent fasting (IF) is less effective that traditional daily dieting at reducing body fat.
News
Non-Invasive Vagus Nerve Stimulation Can Fight Off Fatigue, New Study Claims
Humans have devised endless strategies to stave off tiredness in our busy modern world. Be it industrial-strength coffee, energy drinks of unearthly hues or complex sleep routines, everyone has their own go-tos for staying alert. Now, researchers claim, a new fatigue-fighting technique may have emerged in the form of non-invasive electrical brain stimulation.
News
FDA Controversially Approves Alzheimer's Drug Aducanumab: First To Target Underlying Disease Mechanisms
The US Food and Drug Administration today (June 7) announced the results of their investigation into Biogen’s investigational treatment for Alzheimer’s disease (AD), the monoclonal antibody aducanumab. The agency announced that the compound, under the trade name Aduhelm, is to be approved for treatment, via the FDA’s accelerated approval pathway.
Podcast
Opinionated Science Episode 29: Puppies! And Optogenetic Sight Restoration
In this episode of Opinionated Science, we hear about some revolutionary research that has deployed a cutting-edge genetic technique to restore partial sight to a man who lost his vision to retinitis pigmentosa 40 years previously. And also about a behavioral experiment involving over 300 cute puppies...
News
Puppies’ Ability To Socialize With Humans Is a Heritable Trait
For years, researchers have wondered to what extent this inter-species social bond is driven by dog genetics, or by their environmental interaction with humans. To answer this question, some lucky researchers conducted a study with 375 8-week-old puppies.
Industry Insight
Interview: Behind the E-mmunotherapy Earbud That Could Treat Arthritis
Non-invasive stimulation company Nēsos recently announced that its “e-mmunotherapy” earbud has been granted breakthrough device designation by the US Food and Drug Administration (FDA) for patients with rheumatoid arthritis (RA). We spoke to Konstantinos Alataris, president and CEO of Nēsos, to find out more about the company's device and its potential applications.
News
The Weirdness of Our Dreams Could Explain Their Function, Suggests New Theory
A new theory that takes inspiration from artificial intelligence has suggested that the weirdness of dreams is essential to their purpose.
News
“Mindwriting” Technique Helps Paralyzed Patient Use Brain Activity To Write
A new study has reported a technique allowing a paralysis patient to create text on a screen by simply thinking about handwriting the relevant letters of the alphabet.
News
Dual Vaccination Prevents Allergic Asthma in New Mouse Study
Promising results in a mouse model could point the way to the development of a therapy to treat half of all asthma cases.
Advertisement
